ERWINASE 10 000 IU, powder for solution for injection/for infusion 5 bottles
Active ingredients: CRISANTASPASE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for solution for injection or infusion5 bottlesintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ERWINASE 10 000 UI, poudre pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre pour solution injectable ou pour perfusion
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 5 flacon(s) en verre de 10000 UI
- Marketing authorisation holder
- PORTON BIOPHARMA (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Aug 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69021630CIP75508266CIP133400955082668Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CRISANTASPASEpoudre | 10 000 UI · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.